Sanofi (FRA:SNW2)

Sanofi Statistics

Total Valuation

Sanofi has a market cap or net worth of EUR 105.39 billion. The enterprise value is 112.58 billion.

Market Cap	105.39B
Enterprise Value	112.58B

Important Dates

The next estimated earnings date is Friday, October 24, 2025.

Earnings Date	Oct 24, 2025
Ex-Dividend Date	May 9, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.92%
Shares Change (QoQ)	-1.36%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	58.41%
Float	1.10B

Valuation Ratios

The trailing PE ratio is 11.55 and the forward PE ratio is 10.80.

PE Ratio	11.55
Forward PE	10.80
PS Ratio	2.30
PB Ratio	1.50
P/TBV Ratio	6.08
P/FCF Ratio	11.07
P/OCF Ratio	9.40
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.96, with an EV/FCF ratio of 11.83.

EV / Earnings	12.34
EV / Sales	2.46
EV / EBITDA	8.96
EV / EBIT	11.79
EV / FCF	11.83

Financial Position

The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.32.

Current Ratio	1.27
Quick Ratio	0.81
Debt / Equity	0.32
Debt / EBITDA	1.80
Debt / FCF	2.34
Interest Coverage	16.91

Financial Efficiency

Return on equity (ROE) is 9.00% and return on invested capital (ROIC) is 6.20%.

Return on Equity (ROE)	9.00%
Return on Assets (ROA)	4.60%
Return on Invested Capital (ROIC)	6.20%
Return on Capital Employed (ROCE)	9.78%
Revenue Per Employee	551,871
Profits Per Employee	110,114
Employee Count	82,878
Asset Turnover	0.36
Inventory Turnover	1.30

Taxes

In the past 12 months, Sanofi has paid 1.54 billion in taxes.

Income Tax	1.54B
Effective Tax Rate	19.24%

Stock Price Statistics

The stock price has decreased by -11.89% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-11.89%
50-Day Moving Average	41.36
200-Day Moving Average	45.18
Relative Strength Index (RSI)	62.19
Average Volume (20 Days)	17

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sanofi had revenue of EUR 45.74 billion and earned 9.13 billion in profits. Earnings per share was 7.36.

Revenue	45.74B
Gross Profit	32.62B
Operating Income	9.38B
Pretax Income	7.99B
Net Income	9.13B
EBITDA	12.08B
EBIT	9.38B
Earnings Per Share (EPS)	7.36

Balance Sheet

The company has 15.36 billion in cash and 22.29 billion in debt, giving a net cash position of -6.93 billion.

Cash & Cash Equivalents	15.36B
Total Debt	22.29B
Net Cash	-6.93B
Net Cash Per Share	n/a
Equity (Book Value)	70.28B
Book Value Per Share	57.52
Working Capital	7.96B

Cash Flow

In the last 12 months, operating cash flow was 11.21 billion and capital expenditures -1.70 billion, giving a free cash flow of 9.52 billion.

Operating Cash Flow	11.21B
Capital Expenditures	-1.70B
Free Cash Flow	9.52B
FCF Per Share	n/a

Margins

Gross margin is 71.32%, with operating and profit margins of 20.51% and 19.95%.

Gross Margin	71.32%
Operating Margin	20.51%
Pretax Margin	17.46%
Profit Margin	19.95%
EBITDA Margin	26.42%
EBIT Margin	20.51%
FCF Margin	20.81%

Dividends & Yields

This stock pays an annual dividend of 1.42, which amounts to a dividend yield of 3.30%.

Dividend Per Share	1.42
Dividend Yield	3.30%
Dividend Growth (YoY)	3.06%
Years of Dividend Growth	1
Payout Ratio	19.26%
Buyback Yield	0.92%
Shareholder Yield	4.21%
Earnings Yield	8.66%
FCF Yield	9.03%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	7